Showing results (621-630 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|May 15, 2015
Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditisSnezana Zivancevic-Simonovic, Olgica Mihaljevic, Ivana Majstorovic, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejectionH F Dullens, R A De Weger, M Van der Maas, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. I. Comparison of IgG subclassesS A Eccles, H P Purvies, J M Styles, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Non-cytotoxic asialo-GM1-positive cells exert antimetastatic activityL Strzadala, I Rak, E Ziolo, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytomaR Ophir, M Pecht, D Halperin, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Preparation and analysis of bifunctional immunoconjugates containing monoclonal antibodies OKT3 and BABR1P D Foglesong, M A Winkler, J O Price, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 1998
Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactantsK Ogoshi, M Miyaji, K Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 1998
Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocationJ Zhan, P Stayton, O W Press
Cancer Immunology, Immunotherapy : CII|March 31, 1998
Stable expression of a retrovirally transferred adhesion molecule in a human melanoma-specific cytotoxic T lymohocyte cloneB Cochlovius, V Zawadzki, A Perschl, et al.
Cancer Immunology, Immunotherapy : CII|August 3, 2016
The immunomodulatory, antitumor and antimetastatic responses of melanoma-bearing normal and alcoholic mice to sunitinib and ALT-803: a combinatorial treatment approachKari A Gaither, Alexander A Little, Alisha A McBride, et al.
Pageof 650